Drug intelligence / Profile preview

T-Boost

Development stage
Preclinical
Lead developer
SakuraBio
Modality
CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, TCR-Engineered T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Lymphokine-Activated Killer Cells → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

T-Boost is a proprietary cell therapy platform developed by Sakura Bio designed to enhance the therapeutic potential of immune cells, including T cells and natural killer (NK) cells. The technology focuses on reprogramming these cells to improve their potency, persistence, and resilience within the immunosuppressive tumor microenvironment (TME). T-Boost is engineered to be compatible with various cell therapy modalities such as CAR-T, TCR-T, CAR-NK, and Tumor-Infiltrating Lymphocytes (TILs). By optimizing the metabolic and functional state of the cells, the platform aims to overcome common limitations in treating both solid and hematologic malignancies.

Beyond the preview

Go deeper on T-Boost.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-Boost.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call